Vivo Capital, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Vivo Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$14.8 - $21.15 $17 Million - $24.4 Million	-1,151,622 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$15.08 - $26.0 $5.92 Million - $10.2 Million	392,572 Added 51.72%	1,151,622 $29.3 Million
Q1 2020 May 15, 2020	BUY	$11.0 - $19.76 $8.35 Million - $15 Million	759,050 New	759,050 $11.8 Million
Q3 2019 Nov 13, 2019	SELL	$8.15 - $15.88 $6.87 Million - $13.4 Million	-843,478 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$15.93 - $26.59 $9.22 Million - $15.4 Million	578,600 Added 218.44%	843,478 $15.2 Million
Q3 2018 Nov 13, 2018	BUY	$13.23 - $30.93 $1.04 Million - $2.44 Million	78,805 Added 42.35%	264,878 $6.75 Million
Q2 2018 Aug 10, 2018	BUY	$16.73 - $20.35 $3.11 Million - $3.79 Million	186,073 New	186,073 $3.23 Million

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $634M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.